Serial 97721298
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97721298
- Registration number
- 7590248
- Mark type
- Design / logo
- Filed
- 16 Dec 2022
- Published for opposition
- 13 Jun 2023
- Registered
- 03 Dec 2024
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, nephrological, autoimmune, immunological, ocular, neurological and inflammatory related diseases and disorders
Owner
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Jul 2024 — USE AMENDMENT FILED
- 23 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 24 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED